{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:32:46Z","timestamp":1787016766990,"version":"build-2736575974"},"reference-count":13,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2015,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Data from the Canadian National Gonococcal Antimicrobial Susceptibility Comparison Program, including results from 25 proficiency panels distributed between 2003 and 2012, were analyzed. The average MIC agreement between the participating laboratories ranged from 85.6% to 98.8% over the 10-year period, with the interpretation agreement ranging from 85.7% to 98.1%.<\/jats:p>","DOI":"10.1128\/jcm.02303-15","type":"journal-article","created":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T22:23:37Z","timestamp":1441232617000},"page":"3646-3649","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":18,"title":["Quality Assurance for Antimicrobial Susceptibility Testing of Neisseria gonorrhoeae in Canada, 2003 to 2012"],"prefix":"10.1128","volume":"53","author":[{"given":"Pam","family":"Sawatzky","sequence":"first","affiliation":[{"name":"Bacteriology and Enteric Diseases Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Liu","sequence":"additional","affiliation":[{"name":"Bacteriology and Enteric Diseases Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Anne R.","family":"Dillon","sequence":"additional","affiliation":[{"name":"University of Saskatchewan, Saskatoon, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Allen","sequence":"additional","affiliation":[{"name":"Public Health Ontario Laboratories, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Lefebvre","sequence":"additional","affiliation":[{"name":"Laboratoire de Sant\u00e9 Publique du Qu\u00e9bec, Ste-Anne-de-Bellevue, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Hoang","sequence":"additional","affiliation":[{"name":"British Columbia Public Health Microbiology and Reference Laboratory, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Tyrrell","sequence":"additional","affiliation":[{"name":"Provincial Laboratory for Public Health, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Van Caeseele","sequence":"additional","affiliation":[{"name":"Cadham Provincial Laboratory, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Levett","sequence":"additional","affiliation":[{"name":"Saskatchewan Disease Control Laboratory, Regina, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Martin","sequence":"additional","affiliation":[{"name":"Bacteriology and Enteric Diseases Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","unstructured":"Public Health Agency of Canada. 2015. Notifiable diseases on-line. http:\/\/dsol-smed.phac-aspc.gc.ca\/dsol-smed\/ndis\/charts.php?c=pl. Accessed 4 September 2015."},{"key":"e_1_3_2_3_2","volume-title":"Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. 2012. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/9789241503501\/en\/. Accessed 12 June 2012."},{"key":"e_1_3_2_4_2","volume-title":"National surveillance of antimicrobial susceptibilities of Neisseria gonorrhoeae annual summary 2013","author":"National Microbiology Laboratory","year":"2015","unstructured":"National Microbiology Laboratory. 2015. National surveillance of antimicrobial susceptibilities of Neisseria gonorrhoeae annual summary 2013. Public Health Agency of Canada, Winnipeg, MB, Canada."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp098"},{"key":"e_1_3_2_6_2","volume-title":"CLSI document M100-S24","author":"Clinical and Laboratory Standards Institute","year":"2014","unstructured":"Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. CLSI document M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_7_2","unstructured":"bioM\u00e9rieux. 2012. Etest application guide. bioM\u00e9rieux Marcy l'Etoile France. http:\/\/www.biomerieux-usa.com\/sites\/subsidiary_us\/files\/supplementary_inserts_-_16273_-_b_-_en_-_eag_-_etest_application_guide-3.pdf."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-199607000-00004"},{"key":"e_1_3_2_9_2","unstructured":"Centers for Disease Control and Prevention. 2009. Sexually transmitted disease surveillance 2007 supplement. Gonococcal Isolate Surveillance Project (GISP) annual report 2007. Centers for Disease Control and Prevention Atlanta GA. http:\/\/www.cdc.gov\/std\/gisp2007\/gispsurvsupp2007short.pdf Accessed 30 November 2010."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.31.11.2841-2844.1993"},{"key":"e_1_3_2_11_2","volume-title":"CLSI document M23-A3","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute. 2008. Development of in vitro susceptibility testing criteria and quality control parameters; approved guideline, 3rd ed. CLSI document M23-A3. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"3"},{"key":"e_1_3_2_12_2","volume-title":"Gonococcal antimicrobial susceptibility surveillance in Europe, 2011","author":"Cole M","year":"2013","unstructured":"Cole M, Pitt R, Chisholm S, Ison C. 2013. Gonococcal antimicrobial susceptibility surveillance in Europe, 2011. European Centre for Disease Prevention and Control, Solna, Sweden."},{"key":"e_1_3_2_13_2","volume-title":"Gonococcal antimicrobial susceptibility surveillance in Europe, 2012","author":"Cole M","year":"2014","unstructured":"Cole M, Pitt R, Unemo M, Hellmark B. 2014. Gonococcal antimicrobial susceptibility surveillance in Europe, 2012. European Centre for Disease Prevention and Control, Solna, Sweden."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268809990148"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.02303-15","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.02303-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T03:46:32Z","timestamp":1646451992000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.02303-15"}},"subtitle":[],"editor":[{"given":"E.","family":"Munson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.1128\/JCM.02303-15"],"URL":"https:\/\/doi.org\/10.1128\/jcm.02303-15","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"2015-08-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-09-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-10-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}